Aflibercept Treatment in Polypoidal Choroidal Vasculopathy: Results of a Prospective Study in a Caucasian Population
In this study on a Caucasian population, we showed that aflibercept as a monotherapy provided both a significant visual gain and the regression of polypoidal dilations. Aflibercept use in monotherapy may contribute to reduce the hemorrhagic risk and atrophy linked to PDT.Ophthalmologica
Source: Ophthalmologica - Category: Opthalmology Source Type: research
More News: Angiography | Avastin | Eyes | Lucentis | Opthalmology | Pathology | Polyps | Ranibizumab Injection | Study